Arrowhead Pharmaceuticals Inc logo

ARWR - Arrowhead Pharmaceuticals Inc News Story

$26.12 -0.8  -2.9%

Last Trade - 03/04/20

Sector
Healthcare
Size
Mid Cap
Market Cap £2.17bn
Enterprise Value £1.76bn
Revenue £133.4m
Position in Universe 1273rd / 6308

BRIEF-Arrowhead Reports Interim Clinical Data On Cardiometabolic Candidates ARO-APOC3 And ARO-ANG3

Wed 5th February, 2020 9:55pm
Feb 5 (Reuters) - Arrowhead Pharmaceuticals Inc  ARWR.O :
    * ARROWHEAD REPORTS INTERIM CLINICAL DATA ON CARDIOMETABOLIC
CANDIDATES ARO-APOC3 AND ARO-ANG3
    * ARROWHEAD PHARMACEUTICALS INC - COMPANY TARGETS INITIATION
OF
PIVOTAL STUDIES IN 2020
    * ARROWHEAD PHARMACEUTICALS - FROM SAFETY & TOLERABILITY
PERSPECTIVE, BOTH ARO-ANG3 AND ARO-APOC3 DATA CONTINUE TO LOOK
SIMILAR TO OTHER TRIM CANDIDATES

Source text for Eikon:  ID:nBw3pM0FCa 
Further company coverage:  ARWR.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.